Streetbeat News

CCAP

Crescent Capital BDC, Inc.

https://www.crescentbdc.com

Industry

Asset Management

Crescent Capital BDC, Inc. is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

Open

16.87

Mkt cap

634M

Volume

171K

High

17.18

P/E Ratio

8.60

52-wk high

20.19

Low

16.87

Div yield

0.12

52-wk low

16.81

Crescent Capital BDC and Omega Healthcare Investors are highlighted as attractive income-producing assets with strong fundamentals and high yields. Crescent Capital BDC offers an 11% dividend yield and trades at a 15% discount to NAV, while Omega Healthcare Investors provides a 7.3% yield with potential for capital appreciation.

Portfolio Pulse from

March 12, 2025 | 4:30 pm

Crescent Capital BDC and Cenovus Energy are highlighted as attractive dividend investments due to their high yields and recent price drops. Crescent Capital BDC offers a 9% yield with a strong financial profile, while Cenovus Energy plans to return excess free cash flow to shareholders.

Portfolio Pulse from

February 27, 2025 | 1:30 pm

Crescent Capital BDC, Inc. (CCAP) held its Q4 2024 earnings conference call on February 20, 2025. Key company figures participated, and analysts from Raymond James, Ladenburg, and KBW were present.

Portfolio Pulse from

February 20, 2025 | 8:00 pm

Crescent Capital BDC (CCAP) reported Q4 earnings of $0.55 per share, missing the Zacks Consensus Estimate of $0.56. This is a decrease from $0.61 per share a year ago.

Portfolio Pulse from

February 20, 2025 | 12:30 am

Crescent Capital BDC (CCAP) is expected to surpass earnings estimates in its upcoming report, driven by favorable conditions. Investors are advised to consider this potential when making investment decisions.

Portfolio Pulse from

February 12, 2025 | 4:15 pm

Crescent Capital BDC (CCAP) is expected to surpass earnings estimates in its upcoming quarterly report due to its strong earnings surprise history and favorable conditions.

Portfolio Pulse from

February 04, 2025 | 6:30 pm

Crescent Capital BDC (CCAP) has been upgraded to a Zacks Rank #2 (Buy) due to growing optimism about its earnings prospects.

Portfolio Pulse from

February 04, 2025 | 6:15 pm

Crescent Capital BDC has demonstrated strong financial performance, out-earning its dividend, growing its net asset value, and beating earnings estimates. With no debt maturing until 2026 and ample liquidity, CCAP is well-positioned for future growth.

Portfolio Pulse from

January 09, 2025 | 1:15 pm

Crescent Capital's CCAP is a defensive BDC with a strong focus on first-lien debt and non-cyclical businesses, ensuring high repayment priority and predictable cash flows. It offers a $0.42 quarterly dividend and supplemental distributions, making it an attractive income investment.

Portfolio Pulse from

December 19, 2024 | 6:45 pm

Crescent Capital's Q3 earnings report highlights strong dividend coverage and NAV growth, indicating a resilient portfolio. With a 9.7% dividend yield supported by earnings, and a portfolio valued at $1.6B concentrated in health care and software, CCAP shows financial health and high-quality underwriting.

Portfolio Pulse from

November 13, 2024 | 12:45 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.